Lymphoma News and Research

RSS
Lymphoma is cancer that begins in cells of the immune system. There are two basic categories of lymphomas. One kind is Hodgkin lymphoma, which is marked by the presence of a type of cell called the Reed-Sternberg cell. The other category is non-Hodgkin lymphomas, which includes a large, diverse group of cancers of immune system cells. Non-Hodgkin lymphomas can be further divided into cancers that have an indolent (slow-growing) course and those that have an aggressive (fast-growing) course. These subtypes behave and respond to treatment differently. Both Hodgkin and non-Hodgkin lymphomas can occur in children and adults, and prognosis and treatment depend on the stage and the type of cancer.
Stanford Researchers Develop New Approach to Make Cancer Cells Self-Destruct

Stanford Researchers Develop New Approach to Make Cancer Cells Self-Destruct

Unveiling the Epigenetic Landscape of Blood Cancers

Unveiling the Epigenetic Landscape of Blood Cancers

A Closer Look at CAR T-Cell Therapy — Successes, Challenges, And Future

A Closer Look at CAR T-Cell Therapy — Successes, Challenges, And Future

Understanding the Dynamics of Stem Cells

Understanding the Dynamics of Stem Cells

Researchers Identify Mechanism of Immune Suppression in Ovarian Cancer

Researchers Identify Mechanism of Immune Suppression in Ovarian Cancer

CRISPR and Antibodies Offer New Hope for Improving CAR-T Cell Therapy Outcomes

CRISPR and Antibodies Offer New Hope for Improving CAR-T Cell Therapy Outcomes

Light-Activated Macrophages Show Increased Appetite for Cancer Cells

Light-Activated Macrophages Show Increased Appetite for Cancer Cells

Study Shows the Ability of Protein 'Signatures' to Predict Onset of 67 Diseases

Study Shows the Ability of Protein 'Signatures' to Predict Onset of 67 Diseases

New Research Aims to Improve CAR-T Cell Therapy Effectiveness

New Research Aims to Improve CAR-T Cell Therapy Effectiveness

Newly Discovered CD8-fit Cells Could Revolutionize Cancer Treatment

Newly Discovered CD8-fit Cells Could Revolutionize Cancer Treatment

Machine Learning Program Offers Insights Into Promoter Sequences and Transcription

Machine Learning Program Offers Insights Into Promoter Sequences and Transcription

New Study Links Macrophage Diversity with Patient Survival

New Study Links Macrophage Diversity with Patient Survival

Precision Combination Therapy Better Controls High-Risk Subtypes of B-ALL in Mouse Models

Precision Combination Therapy Better Controls High-Risk Subtypes of B-ALL in Mouse Models

Research Sheds Light on Blood Cell Production in Mouse Skeleton

Research Sheds Light on Blood Cell Production in Mouse Skeleton

DNA Origami Revolutionizes Cancer Immunotherapy: The DoriVac Breakthrough

DNA Origami Revolutionizes Cancer Immunotherapy: The DoriVac Breakthrough

NIH Researchers Map Vulnerable Sites on Epstein-Barr Virus gp42 Protein

NIH Researchers Map Vulnerable Sites on Epstein-Barr Virus gp42 Protein

Mechanism of Cancer Drug Targeting Tumor Suppressor Genes Unveiled

Mechanism of Cancer Drug Targeting Tumor Suppressor Genes Unveiled

Study Unveils Dual Role of 7-DHC in Ferroptosis and Cancer Cell Survival

Study Unveils Dual Role of 7-DHC in Ferroptosis and Cancer Cell Survival

Boosting Post-Transplant Survival: Tailoring Gut Microbiome to Fight GvHD

Boosting Post-Transplant Survival: Tailoring Gut Microbiome to Fight GvHD

Microbial Sensor Unlocks Path to Personalized Blood Stem Cell Therapy

Microbial Sensor Unlocks Path to Personalized Blood Stem Cell Therapy

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.